275
Participants
Start Date
October 18, 2022
Primary Completion Date
March 13, 2025
Study Completion Date
March 13, 2025
Risperidone ISM
Risperidone ISM is administered every 4 weeks
Investigational site number DE-06, Aachen
Investigational site number DE-14, Ansbach
Investigational site number DE-23, Bayreuth
Investigational site number DE-10, Berlin
Investigational site number DE-12, Berlin
Investigational site number DE-15, Berlin
Investigational site number DE-07, Bonn
Investigational site number DE-16, Bonn
Investigational site number DE-02, Chemnitz
Investigational site number DE-03, Dortmund
Investigational site number DE-25, Eberswalde
Investigational Site number DE-01, Essen
Investigational site number DE-08, Greifswald
Investigational site number DE-22, Hamburg
Investigational site number DE-20, Hemer
Investigational site number DE-19, Leipzig
Investigational site number DE-05, Mannheim
Investigational site number DE-04, Munich
Investigational site number DE-09, München
Investigational site number DE-24, Neustadt
Investigational site number DE-13, Werneck
Investigational site number IT-32, Ancona
Investigational site number IT-19, Bolzano
Investigational site number IT-24, Brescia
Investigational site number IT-65, Brindisi
Investigational site number IT-20, Crema
Investigational site number IT-41, Foggia
Investigational site number IT-03, Legnano
Investigational site number IT-47, Manfredonia
Investigational site number IT-06, Milan
Investigational site number IT-42, Milan
Investigational site number IT-18, Montichiari
Investigational site number IT-113, Palermo
Investigational site number IT-44, Putignano
Investigational site number IT-97, Sant'Agata di Militello
Investigational site number IT-90, Vimercate
Investigational site number PT-25, Beja
Investigational site number PT-24, Braga
Investigational site number PT-01, Coimbra
Investigational site number PT-33, Funchal
Investigational site number PT-36, Funchal
Investigational site number PT-20, Guarda
Investigational site number PT-32, Portimão
Investigational site number PT-13, Porto
Investigational site number PT-11, Santo Tirso
Investigational site number PT-27, Tomar
Investigational site number ES-03, Barcelona
Investigational site number ES-45, Barcelona
Investigational site number ES-81, Barcelona
Investigational site number ES-16, Burgos
Investigational site number ES-23, Córdoba
Investigational site number ES-11, Granada
Investigational site number ES-59, Huesca
Investigational site number ES-21, Jaén
Investigational site number ES-70, Jerez de la Frontera
Investigational site number ES-72, L'Hospitalet de Llobregat
Investigational site number ES-60, Las Palmas de Gran Canaria
Investigational site number ES-49, Lleida
Investigational site number ES-51, Lugo
Investigational site number ES-19, Madrid
Investigational site number ES-24, Madrid
Investigational site number ES-66, Madrid
Investigational site number ES-63, Majadahonda
Investigational site number ES-04, Manacor
Investigational site number ES-73, Manresa
Investigational site number ES-65, Mataró
Investigational site number ES-14, Móstoles
Investigational site number ES-18, Murcia
Investigational site number ES-52, Ourense
Investigational site number ES-62, Ponferrada
Investigational site number ES-69, Santander
Investigational site number ES-02, Talavera de la Reina
Investigational site number ES-42, Torrejón
Investigational site number ES-76, Úbeda
Investigational site number ES-31, Vigo
Investigational site number ES-40, Vitoria-Gasteiz
Investigational site number GB-08, London
Rovi Pharmaceuticals Laboratories
INDUSTRY